Evista Medication

Featured Health Expert
9487_4775
EXPERT

Evista vs. Breast Cancer?

After intense research, the maker of anti-osteoporosis drug Evista is asking the FDA to approve its use against breast cancer. A related drug, Tamoxifen, is already widely used by breast cancer survivors. If approved this would be a particularly interesting development because breast cancer survivors at increased risk of osteoporosis, often because of their medication regimes for cancer. In contrast, this medicine might help protect their bones. Read more at:...
Read more

More information on "Evista Medication"

From Our Experts

See more SharePosts »

From Our Sources

More on Menopause »